CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma

Key Points

• Immune dysfunction occurs in diabetic pancreatic adenocarcinoma due to cxcl12 mediation.
• The study highlights the role of cancer-associated fibroblasts in this immune challenge.
• Analysis of tumor microenvironment factors showed significant immune system alterations.
• Findings may suggest novel therapeutic strategies to enhance immune response in this setting.